Inhibition of the AKT/mTOR and erbB pathways by gefitinib, perifosine and analogs of gonadotropin-releasing hormone I and II to overcome tamoxifen resistance in breast cancer cells
Martin L. Block(University of Göttingen), Andreas R. Günthert(University of Lucerne)
Cited by 35
Related Papers
Oncoplastic Breast Consortium consensus conference on nipple-sparing mastectomy
|Breast Cancer Research and Treatment|2018|123